Abnova is the world's largest antibody and recombinant protein manufacturer. Rather than the traditional method of monoclonal antibody production, Abnova is taking a genomic/proteomic approach for the antibody development.
Abnova is the first biotech company successfully integrated the IT-style management and industrial-scale antibody manufacturing. Abnova's goal is to have at least one antibody to every human expressed gene in the human genome.
Abnova manufactures all products of recombinant proteins and antibodies, in-house in their state-of-the art facility. They have implemented an unique platform for immunizing full-length native proteins to generate MaxPab® polyclonal antibody.
They also have multiple clones for their monoclonal antibodies, of which their access is available to customers and partners from academics, research institutions, biotech and pharmaceutical companies.
Country of Origin: Taiwan